These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23562638)

  • 1. Supercritical fluid technology based large porous celecoxib-PLGA microparticles do not induce pulmonary fibrosis and sustain drug delivery and efficacy for several weeks following a single dose.
    Dhanda DS; Tyagi P; Mirvish SS; Kompella UB
    J Control Release; 2013 Jun; 168(3):239-50. PubMed ID: 23562638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
    Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal budesonide-poly(lactide-co-glycolide) microparticles reduce oxidative stress, VEGF expression, and vascular leakage in a benzo(a)pyrene-fed mouse model.
    Bandi N; Ayalasomayajula SP; Dhanda DS; Iwakawa J; Cheng PW; Kompella UB
    J Pharm Pharmacol; 2005 Jul; 57(7):851-60. PubMed ID: 15969944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
    Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
    Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of budesonide-loaded porous PLGA microparticles and their therapeutic efficacy in a murine asthma model.
    Oh YJ; Lee J; Seo JY; Rhim T; Kim SH; Yoon HJ; Lee KY
    J Control Release; 2011 Feb; 150(1):56-62. PubMed ID: 21070826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes.
    Koushik K; Dhanda DS; Cheruvu NP; Kompella UB
    Pharm Res; 2004 Jul; 21(7):1119-26. PubMed ID: 15290850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2012 Aug; 33(22):5574-83. PubMed ID: 22579235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyaluronidase-loaded PLGA microparticles as a new strategy for the treatment of pulmonary fibrosis.
    da Silva Bitencourt C; Gelfuso GM; Pereira PA; de Assis PA; Tefé-Silva C; Ramos SG; Arantes EC; Faccioli LH
    Tissue Eng Part A; 2015 Jan; 21(1-2):246-56. PubMed ID: 25037276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NanoCipro encapsulation in monodisperse large porous PLGA microparticles.
    Arnold MM; Gorman EM; Schieber LJ; Munson EJ; Berkland C
    J Control Release; 2007 Aug; 121(1-2):100-9. PubMed ID: 17604870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable Paclitaxel colloids controls lymphatic metastasis in lung cancer.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Cancer Res; 2009 Feb; 69(3):1174-81. PubMed ID: 19176391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment.
    Feng T; Tian H; Xu C; Lin L; Xie Z; Lam MH; Liang H; Chen X
    Eur J Pharm Biopharm; 2014 Nov; 88(3):1086-93. PubMed ID: 25305583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin.
    Patel B; Gupta V; Ahsan F
    J Control Release; 2012 Sep; 162(2):310-20. PubMed ID: 22800582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization.
    Ni R; Muenster U; Zhao J; Zhang L; Becker-Pelster EM; Rosenbruch M; Mao S
    J Control Release; 2017 Mar; 249():11-22. PubMed ID: 28109773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin-loaded porous PLGA microparticles with surface attached TRAIL for the inhalation treatment of metastatic lung cancer.
    Kim I; Byeon HJ; Kim TH; Lee ES; Oh KT; Shin BS; Lee KC; Youn YS
    Biomaterials; 2013 Sep; 34(27):6444-53. PubMed ID: 23755831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
    Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice.
    Moreno D; Zalba S; Navarro I; Tros de Ilarduya C; Garrido MJ
    Eur J Pharm Biopharm; 2010 Feb; 74(2):265-74. PubMed ID: 19883755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
    Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
    Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel trans-lymphatic drug delivery system: implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres.
    Liu J; Meisner D; Kwong E; Wu XY; Johnston MR
    Biomaterials; 2007 Jul; 28(21):3236-44. PubMed ID: 17434581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.